This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Warfarin overdose

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Seek expert advice.

An algorithm for the management of bleeding and excessive anticoagulation was devised (3):

  • if 3.0 < INR < 6.0 (target INR 2.5) then:
    • reduce warfarin dose/stop warfarin
    • restart warfarin when INR < 5.0
  • if 4.0 < INR < 6.0 (target INR 3.5)
    • reduce warfarin/stop warfarin
    • restart warfarin when INR < 5.0
  • if 6.0 < INR < 8.0 and no bleeding or minor bleeding then:
    • stop warfarin
    • restart when INR < 5.0
  • if INR > 8.0 and no bleeding or minor bleeding then:
    • stop warfarin
    • restart warfarin when INR < 5.0
    • if other risk factors for bleeding then give 0.5-2.5mg of oral vitamin K

  • if major bleeding then:
    • stop warfarin
    • managing bleeding and excessive anticoagulation
      • reversal of anticoagulation with vitamin K is achieved more rapidly with intravenous administration than oral administration
      • in the original guideline an option of 5 mg of vitamin K orally or intravenously was recommended for patients with major bleeding (1), in addition to factor replacement therapy with either a factor concentrate or fresh frozen plasma (FFP). Subsequent guidance (5) now considers that, in patients with major bleeding, reversal with intravenous vitamin K is preferable. A dose of either 5 or 10 mg is recommended.
        • complete and rapid reversal of over-anticoagulation is more readily achieved with a factor concentrate than with FFP
        • intravenous vitamin K should be given if reversal is to be sustained
      • the guidance recommends (5,6)
        • reversal of anticoagulation in patients with major bleeding requires administration of a factor concentrate (prothrombin factor concentrate) in preference to FFP, when this is available and administration of intravenous rather than oral vitamin K

Unexpected bleeding at therapeutic levels:

  • investigate for possible cause e.g. alimentary or renal disease


  • there is evidence that in patients receiving warfarin and who had an INR between 4.5 and 10.0, low dose vitamin K lowered the INR to between 1.8 and 3.2 the day after administration (2)
    • however a more recent large randomized controlled trail including more than 700 patients with INR values between 4.5 and 10.0 failed to show a statistically significant reduction in major bleeding events in the group of patients randomized to 1.25 mg of oral vitamin K compared with the group of patients randomized to placebo (3)


  1. Guidelines on oral anticoagulation: third edition . British Journal of Haematology 1998;101 (2): 374-387
  2. Crowther MA et al. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. Lancet 2000; 356: 1551-3.
  3. Crowther MA, Ageno W, Garcia D, et al. Effectiveness of low dose oral vitamin K for patients with elevated INR values: results of randomized trial examining clinical outcomes. J Thromb Haemost 2007;5 Suppl 2:P-S-219
  4. MeReC Bulletin (1997); 8(1): 1-4.
  5. Guidelines on oral anticoagulation (warfarin): third edition - 2005 update. British Journal of Haematol 2006; 132(3): 277-85
  6. NICE (November 2015). Blood transfusion

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page